Collaborative scientific partnerships focused on solving complex biological challenges, advancing therapeutic discovery, and generating high-value translational data.

Bespoke screening and profiling projects powered by integrated high-throughput, high-content imaging, in vitro, cell-based, and high-content flow cytometry platforms. We provide end-to-end assessment of compound activity, mitochondrial function, cellular phenotypes, and safety, generating multidimensional datasets to support hit discovery, lead optimisation, and mechanistic studies.

Our proprietary screening technologies are engineered for high-sensitivity detection of mitochondrial loss of function, enabling earlier and more comprehensive identification of mitochondrial liabilities. This provides actionable insights into compound effects on mitochondrial biology and supports confident progression of promising candidates.

Leverage our proprietary screening technologies, original biological data platforms, and assay datasets to enhance your internal drug discovery capabilities. We offer flexible models for technology access, data integration, and assay deployment, enabling seamless incorporation of our capabilities into existing discovery and development workflows.

From target identification and validation to HTS, hit discovery, lead optimisation and candidate evaluation, we design and execute bespoke discovery projects across the full spectrum of in vitro and in cellulo biology. Our multimodal approach integrates primary and disease-relevant models, phenotypic and mechanistic assays, advanced screening technologies, and toxicity profiling to deliver comprehensive, decision-ready datasets tailored to each project.

Our integrated technology platforms support every stage of therapeutic discovery, from early target validation and compound screening to functional characterisation and safety assessment. We combine advanced screening technologies with deep expertise in mitochondrial biology to deliver high-quality, actionable data.

Our Capabilities Include

• Flow Cytometry – High-parameter cellular analysis and phenotypic profiling.

• In Vitro Screening – Enzyme activity, substrate conversion, inhibitor identification, and potency assessment.

• High-Throughput Screening – Scalable screening for large compound libraries and lead identification.

• In Cellulo Therapeutic Profiling – Functional assessment of therapeutic candidates in physiologically relevant cellular models.

• Mitochondrial Function & Metabolic Profiling – Comprehensive analysis of mitochondrial health, cellular bioenergetics, and metabolic activity.

• Mitochondrial Toxicity Screening – Early detection and characterisation of mitochondrial liabilities to improve candidate selection.

• High-Content Imaging – Multiparametric imaging to quantify cellular phenotypes, organelle dynamics, and drug responses.

• Mechanism of Action Studies – Functional assays to investigate target engagement and biological response.

• In Vitro & In Cellulo Assays – Flexible assay formats spanning biochemical, cellular, and translational applications.

• Data Analysis & Scientific Interpretation – Comprehensive reporting with expert biological insight to support confident decision-making.

• Innovative proprietary screening technologies

• Expertise in mitochondrial biology and therapeutic development

• Flexible collaboration and licensing models

• Rapid assay development and implementation

• Actionable data to support confident decision-making

• Dedicated scientific support throughout every stage of your project